- Home
- TALK vs DNA Comparison
TALK vs DNA Comparison
Compare TALK & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- DNA
- Stock Information
- Founded
- TALK 2012
- DNA 2008
- Country
- TALK United States
- DNA United States
- Employees
- TALK N/A
- DNA N/A
- Industry
- TALK Medical/Nursing Services
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TALK Health Care
- DNA Health Care
- Exchange
- TALK Nasdaq
- DNA Nasdaq
- Market Cap
- TALK 534.6M
- DNA 562.1M
- IPO Year
- TALK N/A
- DNA N/A
- Fundamental
- Price
- TALK $3.01
- DNA $10.82
- Analyst Decision
- TALK Buy
- DNA Hold
- Analyst Count
- TALK 5
- DNA 6
- Target Price
- TALK $4.38
- DNA $37.80
- AVG Volume (30 Days)
- TALK 2.6M
- DNA 1.9M
- Earning Date
- TALK 02-20-2025
- DNA 02-25-2025
- Dividend Yield
- TALK N/A
- DNA N/A
- EPS Growth
- TALK N/A
- DNA N/A
- EPS
- TALK 0.01
- DNA N/A
- Revenue
- TALK $187,593,000.00
- DNA $217,951,000.00
- Revenue This Year
- TALK $28.27
- DNA N/A
- Revenue Next Year
- TALK $23.44
- DNA N/A
- P/E Ratio
- TALK $442.17
- DNA N/A
- Revenue Growth
- TALK 25.02
- DNA N/A
- 52 Week Low
- TALK $1.60
- DNA $5.26
- 52 Week High
- TALK $4.36
- DNA $64.40
- Technical
- Relative Strength Index (RSI)
- TALK 36.07
- DNA 43.22
- Support Level
- TALK $2.94
- DNA $11.21
- Resistance Level
- TALK $4.36
- DNA $15.96
- Average True Range (ATR)
- TALK 0.30
- DNA 1.85
- MACD
- TALK -0.07
- DNA -0.40
- Stochastic Oscillator
- TALK 5.92
- DNA 0.08
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.